121 filings
Page 5 of 7
8-K
yeg5l q3iiyex82
6 Aug 15
Regulation FD Disclosure
12:00am
8-K
vg439xu5xr7vem526k0
6 Aug 15
Regulation FD Disclosure
12:00am
UPLOAD
38v16ewqplo w05q8
6 Aug 15
Letter from SEC
12:00am
UPLOAD
cm01u9kx
19 Jun 15
Letter from SEC
12:00am
8-K
wh1jthbqa
11 May 15
Regulation FD Disclosure
12:00am
8-K
0bq5fh6ldcrrov 02
22 Apr 15
Entry into a Material Definitive Agreement
12:00am
8-K
03fiod v4rl11jhi8
18 Mar 15
Other Events
12:00am
8-A12B
4yyohh q9fh2nz
17 Mar 15
Registration of securities on exchange
12:00am
8-K
hjtvdd s82624eq1b1
16 Mar 15
European Commission Clears Actavis’ Pending Acquisition of Allergan
12:00am
8-K
mrqs44t0fy br
13 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
h36uchk2zpw
12 Mar 15
Actavis Announces Closing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan
12:00am
8-K
svndhec
10 Mar 15
Actavis and Allergan Shareholders Approve Proposals
12:00am
8-K
8a2 v0blr0
6 Mar 15
Entry into a Material Definitive Agreement
12:00am
424B2
blfgs7p5a1vokr2024
5 Mar 15
Prospectus for primary offering
12:00am
8-K
1ee34f
4 Mar 15
Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan
12:00am
8-K
9at3bo3fks7h3sq q5kp
2 Mar 15
Actavis Announces Proposed Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan
12:00am
8-K
k9i1ob55
2 Mar 15
Entry into a Material Definitive Agreement
12:00am
424B5
z05gizmf7ow6nbgdd4
2 Mar 15
Prospectus supplement for primary offering
12:00am